Cardiovascular epigenetics: from DNA methylation to microRNAs - PubMed (original) (raw)
Review
. 2013 Jul-Aug;34(4):883-901.
doi: 10.1016/j.mam.2012.08.001. Epub 2012 Sep 6.
Affiliations
- PMID: 22981780
- DOI: 10.1016/j.mam.2012.08.001
Review
Cardiovascular epigenetics: from DNA methylation to microRNAs
Silvia Udali et al. Mol Aspects Med. 2013 Jul-Aug.
Abstract
Epigenetic phenomena are defined as heritable mechanisms that establish and maintain mitotically stable patterns of gene expression without modifying the base sequence of DNA. The major epigenetic features of mammalian cells include DNA methylation, post-translational histone modifications and RNA-based mechanisms including those controlled by small non-coding RNAs (miRNAs). The impact of epigenetic mechanisms in cardiovascular pathophysiology is now emerging as a major player in the interface between genotype to phenotype variability. This topic of research has strict implications on disease development and progression, and opens up possible novel preventive strategies in cardiovascular disease. An important aspect of epigenetic mechanisms is that they are potentially reversible and may be influenced by nutritional-environmental factors and through gene-environment interactions, all of which have an important role in complex, multifactorial diseases such as those affecting the cardiovascular system. Gene expression regulation through the interplay of DNA methylation and histone modifications is well-established, although the knowledge about the function of epigenetic signatures in cardiovascular disease is still largely unexplored. The study of epigenetic markers is, therefore, a very promising frontier of science which may aid in a deeper understanding of molecular mechanisms underlying the modulation of gene expression in the biomolecule pathways linked to cardiovascular diseases. This review focuses on up-to-date knowledge pertaining to the role of epigenetics, from DNA methylation to miRNAs, in major cardiovascular diseases such as ischemic heart disease, hypertension, heart failure and stroke.
Copyright © 2012. Published by Elsevier Ltd.
Similar articles
- Epigenetics and arterial hypertension: the challenge of emerging evidence.
Friso S, Carvajal CA, Fardella CE, Olivieri O. Friso S, et al. Transl Res. 2015 Jan;165(1):154-65. doi: 10.1016/j.trsl.2014.06.007. Epub 2014 Jun 25. Transl Res. 2015. PMID: 25035152 Review. - Nutritional influences on epigenetics and age-related disease.
Park LK, Friso S, Choi SW. Park LK, et al. Proc Nutr Soc. 2012 Feb;71(1):75-83. doi: 10.1017/S0029665111003302. Epub 2011 Nov 4. Proc Nutr Soc. 2012. PMID: 22051144 Review. - Hypertensive epigenetics: from DNA methylation to microRNAs.
Wang J, Gong L, Tan Y, Hui R, Wang Y. Wang J, et al. J Hum Hypertens. 2015 Oct;29(10):575-82. doi: 10.1038/jhh.2014.132. Epub 2015 Jan 29. J Hum Hypertens. 2015. PMID: 25631220 Review. - Epigenetics: a new link between nutrition and cancer.
Supic G, Jagodic M, Magic Z. Supic G, et al. Nutr Cancer. 2013;65(6):781-92. doi: 10.1080/01635581.2013.805794. Nutr Cancer. 2013. PMID: 23909721 Review. - Epigenetic biomarkers: A new perspective in laboratory diagnostics.
García-Giménez JL, Sanchis-Gomar F, Lippi G, Mena S, Ivars D, Gomez-Cabrera MC, Viña J, Pallardó FV. García-Giménez JL, et al. Clin Chim Acta. 2012 Oct 9;413(19-20):1576-82. doi: 10.1016/j.cca.2012.05.021. Epub 2012 Jun 1. Clin Chim Acta. 2012. PMID: 22664147 Review.
Cited by
- CAMTA1 gene affects the ischemia-reperfusion injury by regulating CCND1.
Liu Y, Shang G, Zhang X, Liu F, Zhang C, Li Z, Jia J, Xu Y, Zhang Z, Yang S, Zhou B, Luan Y, Huang Y, Peng Y, Han T, He Y, Zheng H. Liu Y, et al. Front Cell Neurosci. 2022 Sep 9;16:868291. doi: 10.3389/fncel.2022.868291. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36159397 Free PMC article. - Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases.
Wang Y, Miao X, Liu Y, Li F, Liu Q, Sun J, Cai L. Wang Y, et al. Oxid Med Cell Longev. 2014;2014:641979. doi: 10.1155/2014/641979. Epub 2014 Feb 18. Oxid Med Cell Longev. 2014. PMID: 24693336 Free PMC article. Review. - DNA methylation dysregulations in valvular atrial fibrillation.
Shen K, Tu T, Yuan Z, Yi J, Zhou Y, Liao X, Liu Q, Zhou X. Shen K, et al. Clin Cardiol. 2017 Sep;40(9):686-691. doi: 10.1002/clc.22715. Epub 2017 Aug 28. Clin Cardiol. 2017. PMID: 28846808 Free PMC article. - Cellular Effects of Butyrate on Vascular Smooth Muscle Cells are Mediated through Disparate Actions on Dual Targets, Histone Deacetylase (HDAC) Activity and PI3K/Akt Signaling Network.
Mathew OP, Ranganna K, Mathew J, Zhu M, Yousefipour Z, Selvam C, Milton SG. Mathew OP, et al. Int J Mol Sci. 2019 Jun 14;20(12):2902. doi: 10.3390/ijms20122902. Int J Mol Sci. 2019. PMID: 31197106 Free PMC article. - Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients.
Nguyen A, Mamarbachi M, Turcot V, Lessard S, Yu C, Luo X, Lalongé J, Hayami D, Gayda M, Juneau M, Thorin-Trescases N, Lettre G, Nigam A, Thorin E. Nguyen A, et al. PLoS One. 2016 Apr 21;11(4):e0153920. doi: 10.1371/journal.pone.0153920. eCollection 2016. PLoS One. 2016. PMID: 27101308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources